Revenue from Contracts with Customers (Tables)

12 Months Ended

Sep. 30, 2022

Revenue from Contract with Customer [Abstract]

Revenue by Reporting Unit

	Year ended September 30,
	2022		2021			2020
Significant Business Line
Life Sciences Products	$	199,230	$	199,606	$	129,759
Sample Repository Solutions		105,331		88,922		89,847
Genomic Services		250,937		225,175		168,931
Total	$	555,498	$	513,703	$	388,537

Remaining Performance Obligations

	As of September 30, 2022
	Less than 1 Year		Greater than 1 Year		Total
Remaining Performance Obligations	$	45,365	$	34,844	$	80,209